The Potential Role of Perfluorochemicals (PFCS) in Diagnostic Imaging

References

• Slinn DSL, Green SW. Fluorocarbon Fluids For Use in the Electronics Industry. Preparation, Properties, and Industrial Applications of Organofluorine Compounds, RE Banks. Ellis Horwood Limited, Chischester, England 1982; 45–82
   Google Scholar
• Ubel FA, Sorenson SD, Roach DE. Health Status of Plant Workers Exposed to Fluorochemicals: A Preliminary Report. Amer. Industrial Hygiene Assoc Jour 1980; 41: 584–589
   PubMed Web of Science ®Google Scholar
• Riess JG. Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships. Artificial Organs 1984; 8: 44–56
   PubMed Web of Science ®Google Scholar
• Naito R, Yokohama K. The Green Cross Corp Technical Information Series, no. 5. Perfluorochemical Blood Substitutes FC-43 Emulsion, Fluosol-DA 20% and 35% for Preclinical Studies as a Candidate for Erythrocyte Substitution. 1981; 37(84)161–169
   Google Scholar
• Tremper KK, Freidman AE, Levine EM, et al. The Preoperative Treatment of Severely Anemic Patients With a Perfluorochemical Oxygen-Transport Fluid, Fluosol-DA. N Engl J Med 1982; 307: 277–283
   PubMed Web of Science ®Google Scholar
• Bruneton JN, Falewee MN, Francois E, et al. Spleen, and Vessels: Preliminary Clinical Results of CT with Perfluorooctylbromide. Radiology 1989; 170: 179–183
   PubMed Web of Science ®Google Scholar
• Wootton SL, Coley BD, Hilton SVW, et al. Value of Brominated Fluorocarbons for the Radiographic diagnosis of Small Bowel Obstruction: Comparison with other Contrast Agents in Rats. AJR, in press
   Web of Science ®Google Scholar
• Wolfson MR, Stern RG, Kechner N, Sekins KM, Shaffer TH. Utility of a Perlfluorochemical Liquid for Pulmonary Diagnostic Imaging. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Mattrey RF. Perfluorooctylbromide: A New Contrast Agent for CT, Sonography, and MR Imaging. Amer J Roentgenology. 1989; 152: 247–252
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Hajek P, Gylys-Morin V, et al. Perfluorochemicals as Gastrointestinal Contrast Agents for MRI: Preliminary Studies in Rats and Man. AJR 1987; 148: 1259–1263
   PubMed Web of Science ®Google Scholar
• Schumacher DJ, Steinbach GC, Keane S, et al. Comparison of Artifacts Generated by Oral MRI Contrast Agents in-vitro. AUR, Lake Buena Vista, FL, 3/91. Invest Radiol. 1991; 26: 1125
   Google Scholar
• Rubin DL, Muller HH, Nino-Murcia M, et al. Intraluminal Contrast Enhancement and MR Visualization of the Bowel Wall: Efficacy of PFOB. JMRI 1991; 1: 371–380
   Web of Science ®Google Scholar
• Eilenberg SS, Tartar VM, Mattrey RF. Reducing Magnetic Susceptibility Differences Using Liquid Fluorocarbon Pads (Sat Pad(tm)): Results with Spectral Presaturation of Fat. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Clark LC, Ackerman JL, Thomas SR, Millard RW. High Contrast Tissue and Blood Oxygen Imaging Based on Fluorocarbon 19F NMR Relaxation. Magn Reson Med 1984; 1: 135–136
   Web of Science ®Google Scholar
• Le Blanc M., Riess JG. Artificial Blood Substitutes Based on Perfluorochemicals. Preparation, Properties, and Industrial Applications of Organofluorine Compounds, RE Banks. Ellis Horwood Limited, Chischester, England 1982; 83–138
   Google Scholar
• Mason RP. Non-invasive Physiology: ¹⁹F NMR of Perfluorocarbons. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Guo Q, Mattrey RF, Guclu MS, et al. Monitoring OF pO₂ by Spin-Spin Relaxation Rate 1/T2 of ¹⁹F in a Rabbit Abscess Model. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Canty JM, Jr., Judd RM., Brody AS., Klocke FJ. First-pass Entry of Nonionic Contrast Agent Into the Myocardial Extravascular Space: Effects on Radiographic Estimates of Transit-time and Blood Volume. Circulation 1991; 84: 2071–8
   PubMed Web of Science ®Google Scholar
• Jain RK. Determinants of Tumor Blood Flow: a Review. Cancer Res 1988; 48: 2641–58
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Peck WW, Slutsky RA, Higgins CB. Perfluoroctylbromide as a Blood Pool Imaging Agent for Computed Tomography. J Comput Assist Tomogr 1984; 8: 739–744
   PubMed Web of Science ®Google Scholar
• Hillman BJ, Stanley ML, Tracey P, et al. CT Determination of Renal and Hepatic Microvascular Volumes in Experimental Acute Renal Failure. Invest Radiol 1982; 17: 41–45
   PubMed Web of Science ®Google Scholar
• Mattrey RF. Potential role of Perfluorooctylbromide in the Detection and Characterization of Liver Lesions with CT. Radiology. 1989; 170: 18–20
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Long DM, Multer F, et al. Perfluoroctylbromide: A Reticuloendothelial Specific and a Tumor Imaging Agent for Computed Tomography. Radiology 1982; 145: 755–758
   PubMed Web of Science ®Google Scholar
• Vermess M, Doppman JL, Sugarbaker PH, et al. Computed Tomography of The Liver and Spleen with Intravenous Lipoid Contrast Material: Review of 60 Examinations. AJR 1982; 138: 1063–1071
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Vermess M, et al. Improved Detection of Focal Lesions with Computerized Tomographic Examination of the Liver Using Ethiodized Oil Emulsion (EOE-13) Liver Contrast. Cancer 1984; 54: 1489–95
   PubMed Web of Science ®Google Scholar
• Patronas N, Miller DL, Girton M. Experimental Comparison of EOE-13 and Perfluoroctylbromide for The CT Detection of Hepatic Metastases. Invest Radiol 1984; 19: 570–573
   PubMed Web of Science ®Google Scholar
• Steinbach GC, Lim GM, Arellano RS, et al. The Use of Imagent BP as a Blood Pool Contrast Agent to Visualize and Quantitate Liver Tumor Burden. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Baker KG, Wrigley R, Saunders HB, Mattrey RF. Efficacy of Imagent BP at 1.5mL/kg in a Rabbit Liver Tumor Model. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Sanchez V, Zarif L, Greiner J, et al. Novel Injectable Fluorinated Contrast Agents with Enhanced Radiopacity. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Adam G, Gunther RW, Schiffer C, et al. Computed Tomographic Enhancement of the Liver, Liver Abscesses, Spleen, and Major Vessels with Perfluorooctylbromide Emulsion. Influence of Dosage and Injection Velocity in an Animal Model. Invest Radiol 1992; 27: 698–705
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Mitten R, Peterson T, Long CD. Vascular Ultrasonic Enhancement of Tissues with Perfluoroctylbromide for Renal Tumor Detection (abstr). Radiology 1987; 165: 76, Supp
   Google Scholar
• Ratner AV, Muller HH, Bradley-Simpson B, et al. Detection of Tumors with 19F Magnetic Resonance Imaging. Invest Radiol 1988; 23: 361–4
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Andre MP, Campbell J, et al. Specific Enhancement of Intra-Abdominal Abscesses with Perfluoroctylbromide for Computed Tomography. Invest Radiol 1984; 19: 438–446
   PubMed Web of Science ®Google Scholar
• Miller ML, Stinnett D, Clark LC, Jr. Ultrastructure of Tumoricidal Peritoneal Exudate Cells Stimulated In-vivo by Perfluorochemical Emulsions. J. Reticuloendothelial Soc 1980; 27: 105–18
   PubMedGoogle Scholar
• Mattrey RF, Brown JJ, Shelton RE, et al. Use of Perfluorooctylbromide (PFOB) to Detect Liver Abscesses with CT: Safety and Efficacy. Invest Radiol. 1991; 26: 792–798
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Scheible FW, Gosink BB, et al. Perfluoroctylbromide: A Liver and Spleen Specific and a Tumor Imaging Ultrasound Contrast Material. Radiology 1982; 145: 759–762
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Leopold GR, van Sonnenberg E, et al. Perfluorochemicals as Liver and Spleen Seeking Ultrasound Contrast Agents. J Ultrasound Med 1983; 2: 173–176
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Andre MP. Ultrasonic Enhancement of Myocardial Infarction with Perfluorocarbon Compounds. Amer J Cardiol 1984; 54: 206–210
   PubMed Web of Science ®Google Scholar
• Mattrey RF, Strich G, Shelton RE, et al. Perfluorochemicals as Ultrasound Contrast Agents for Tumor Imaging and Hepatosplenography: Preliminary Clinical Results. Radiology 1987; 163: 339–443
   PubMed Web of Science ®Google Scholar
• Sartoris DJ, Guerra J, Jr, Mattrey RF., et al. Perfluoroctylbromide as a Contrast Agent for Computed Tomographic Imaging of Septic and Aseptic Arthritis. Invest Radiol 1986; 21: 49–55
   PubMed Web of Science ®Google Scholar
• Wolf G, Long DM, Riess JG. Percutaneous Lymphography with Perfluoroctyl bromide Emulsions. Presented at the annual meeting of Radiological Society of North America, Chicago 1990. Radiology 1990; 177: 366
   Google Scholar
• Ikomi F, Hanna G, Schmid-Schonbein GW. Intracellular and Extracellular Transpport of Perfluorocarbon Emulsion From Subcutaneous Tissue to Regional Lymphatics. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Hanna G, Saewert D, Shorr J, et al. Preclinical and Clinical Studies on Lymphnode Imaging Using Perflubron Emulsion. ISBS, San Diego 1993, These Proceedings
   Google Scholar
• Hilpert PL, Mattrey RF, Mitten R, Peterson T. Intravenous Ultrasonic Contrast Agents to Enhance Systemic Arterial Doppler Signal. Presented at the annual meeting of the Association of University Radiologists. New Orleans May, 1988
   Google Scholar
• Coley BD, Mattrey RF, Roberts A, Keane SF. The Potential Role of PFOB Enhanced Sonography of the Kidney: PART II-Detection of Partial Infarction. Kidney International. 1990; 39: 740–745
   Web of Science ®Google Scholar
• Coley BD, Mattrey RF, Mitten R, Peterson T. The Physiologic Basis of the Radiodense Renal Medulla After the Administration of Blood Pool Contrast Agent, PFOB. Invest Radiol. 1990; 25: 1287–1293
   PubMed Web of Science ®Google Scholar
• Munzing D, Mattrey RF, Reznik VM, et al. The Potential Role of PFOB Enhanced Sonography of the Kidney: PART I-Detection of Renal Function and Acute Tubular Necrosis. Kidney International. 1990; 39: 733–739
   Web of Science ®Google Scholar
• Lim GM, Coley BD, Arellano RS, Mattrey RF. Perflubron Emulsion Allows Sonographic Distinction of Normal from Obstructed Kidneys. Presented at the annual meeting of Radiological Society of North America, Chicago 1992. Radiology 1992; 185: 287
   Web of Science ®Google Scholar
• Behan M, O'Connell D, Mattrey RF, Carney DN. Perfluorooctylbromide As a Contrast Agent For Sonography and Computed Tomography. AJR 1993; 160: 399–405
   PubMed Web of Science ®Google Scholar
• Satterfield R, Tarter VM, Schumacher DJ, et al. Comparison of Different Perfluorocarbons as Ultrasound Contrast Agents. Invest Rad 1993; 28: 325–331
   PubMed Web of Science ®Google Scholar